|
Symbol Name ID |
Sle1
systemic lupus erythmatosus susceptibility 1 MGI:105969 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Sle1NZM2410/Aeg/Sle1NZM2410/Aeg Sle3NZM2410/Aeg/Sle3NZM2410/Aeg B6;NZM-Sle1NZM2410/Aeg Sle2NZM2410/Aeg Sle3NZM2410/Aeg/LmoJ |
abnormal marginal zone B cell physiology | J:138314 |
| increased marginal zone B cell number | J:138314 | |
| Sle1NZW/Sle1NZW Sles1NZW/Sles1NZW involves: C57BL/6 * NZW |
abnormal T cell physiology | J:100678 |
| decreased susceptibility to systemic lupus erythematosus | J:100678 | |
| Sle1NZW/Sle1NZW Tg(Tnfsf13b)1Fma/0 involves: C57BL/6 * DBA/2J * NZW |
glomerulonephritis | J:134128 |
| increased B cell number | J:134128 | |
| increased IgG level | J:134128 | |
| increased IgM level | J:134128 | |
| increased marginal zone B cell number | J:134128 | |
| increased susceptibility to systemic lupus erythematosus | J:134128 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||